PPrivate Fund Data
CompaniesFundsPeopleRankingsScreener

Abingworth Clinical Co-Development Fund 2 LP

Private Equity FundFund ID 805-2794267530United Kingdom
Gross assets
$279.8M
Min. investment
Beneficial owners
112
Size rank
Top 26%
Audited
Yes
Structure
Standalone

About this fund

Abingworth Clinical Co-Development Fund 2 LP is a private equity fund managed by Carlyle Investment Management L.L.C.. The fund reports $279.8 million in gross assets, placing it among the top 26% of private funds by size. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.

Fund details

Fund ID805-2794267530
Fund typePrivate Equity Fund
3(c)(1) exclusionYes
3(c)(7) exclusionYes
Master fundNo
Feeder fundNo
Fund of fundsNo
Relies on exemption from registrationYes
Annual auditYes
Prepared per GAAPYes
Sub-advisedYes
Sales limited to qualified investorsYes
% of assets independently valued0%

Other funds from this manager

FundTypeGross assets
Carlyle Partners VIIPrivate Equity$22.22B
Carlyle Partners VIIIPrivate Equity$14.33B
Carlyle Realty Partners IXReal Estate$7.34B
See all 313 funds from this manager — unlock the full record.
Join to unlock · $37/mo

Frequently asked questions

How large is Abingworth Clinical Co-Development Fund 2 LP?

Abingworth Clinical Co-Development Fund 2 LP reports $279.8 million in gross assets, among the top 26% of private funds by size.

Who manages Abingworth Clinical Co-Development Fund 2 LP?

Abingworth Clinical Co-Development Fund 2 LP is managed by Carlyle Investment Management L.L.C.

Does Abingworth Clinical Co-Development Fund 2 LP disclose returns?

No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.

Service providers

Prime broker
None reported
Custodian
Administrator

Reported gross assets

$279.8M▲ 32%
Jan '25 — $211.3MFeb '25 — $211.3MMar '25 — $206.7MApr '25 — $206.7MMay '25 — $206.7MJun '25 — $206.7MJul '25 — $206.7MAug '25 — $206.7MSep '25 — $206.7MOct '25 — $206.7MNov '25 — $206.7MDec '25 — $206.7MJan '26 — $206.7MFeb '26 — $206.7MMar '26 — $279.8MApr '26 — $279.8MMay '26 — $279.8MJun '26 — $279.8M
Jan '25Form ADV, monthlyJun '26

How this fund compares

Gross assetsTop 26%
Larger than 74% of 67,041 private funds
Gross assets vs Private Equity FundsTop 22%
Larger than 78% of 31,066 private equity funds

Investor base

Adviser & related persons2%
Funds of funds22%
Non-U.S. persons91%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.